• Thumbnail for European Medicines Agency
    The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products. Prior...
    43 KB (3,701 words) - 10:53, 29 April 2024
  • ensuring that medicines and medical devices work and are acceptably safe. The MHRA was formed in 2003 with the merger of the Medicines Control Agency (MCA) and...
    24 KB (2,284 words) - 11:01, 6 March 2024
  • Thumbnail for African Medicines Agency
    similar model to that of the European Medicines Agency, it is intended to have a wide scope covering medicines, traditional medicine, and medical devices. The...
    20 KB (1,881 words) - 14:52, 6 June 2023
  • responsible for the regulatory activity of pharmaceuticals in Italy. European Medicines Agency Istituto Superiore di Sanità Official website v t e v t e...
    464 bytes (37 words) - 18:24, 13 May 2024
  • Thumbnail for Semaglutide
    European Medicines Agency (EMA). 29 January 2020. Archived from the original on 14 August 2020. Retrieved 26 September 2020. "Wegovy EPAR". European Medicines...
    66 KB (5,379 words) - 05:32, 9 May 2024
  • Thumbnail for Dapagliflozin
    © European Medicines Agency. Reproduction is authorized provided the source is acknowledged. "Dapagliflozin Viatris EPAR". European Medicines Agency. 4...
    53 KB (4,937 words) - 05:04, 12 May 2024
  • their lifecycle. Drug-related authorities such as the European Medicines Agency (EMA) of the European Union, the United States Food and Drug Administration...
    95 KB (6,479 words) - 21:14, 31 March 2024
  • Thumbnail for Pneumococcal conjugate vaccine
    which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged. "Synflorix EPAR". European Medicines Agency (EMA). 17...
    50 KB (4,208 words) - 01:34, 22 April 2024
  • Thumbnail for Enclomifene
    European Medicines Agency in the European Union. In January 2018, the Committee for Medicinal Products for Human Use of the European Medicines Agency...
    17 KB (1,585 words) - 19:15, 28 April 2024
  • Thumbnail for Tirzepatide
    the brand name Zepbound. In November 2023, the UK Medicines and Healthcare products Regulatory Agency revised the indication for tirzepatide to include...
    42 KB (3,387 words) - 15:37, 9 May 2024
  • Thumbnail for N-Nitrosodimethylamine
    is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged. "Nitrosamine impurities". European Medicines Agency (EMA)...
    25 KB (2,390 words) - 04:57, 9 May 2024
  • Thumbnail for European Pharmacopoeia
    and methods of analysis for medicines. These standards apply to medicines for both human and veterinary use. The European Pharmacopoeia has a legally...
    11 KB (1,225 words) - 06:47, 24 April 2024
  • Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion, recommending the granting of...
    20 KB (1,433 words) - 07:08, 3 March 2024
  • Thumbnail for Pholcodine
    medicines-cancelled-tga-and-recalled-pharmacies-safety-reasons "EMA recommends withdrawal of pholcodine medicines from EU market". European Medicines...
    17 KB (1,566 words) - 16:24, 15 February 2024
  • Thumbnail for Dupilumab
    viral infections. The most common side effects reported by the European Medicines Agency (EMA) include injection-site reactions (such as redness, swelling...
    22 KB (1,841 words) - 22:50, 30 April 2024
  • Thumbnail for European Directorate for the Quality of Medicines & HealthCare
    The European Directorate for the Quality of Medicines & HealthCare (EDQM) is a Directorate and partial agreement of the Council of Europe that traces...
    33 KB (3,770 words) - 16:29, 27 April 2024
  • 2023, the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) recommended a conditional marketing authorization for epcoritamab...
    13 KB (821 words) - 04:46, 9 May 2024
  • Thumbnail for Oxford–AstraZeneca COVID-19 vaccine
    vaccine has since been approved by several medicine agencies worldwide, such as the European Medicines Agency (EMA), and the Australian Therapeutic Goods...
    213 KB (16,972 words) - 00:44, 9 May 2024
  • Adalimumab (category World Health Organization essential medicines)
    EPAR". European Medicines Agency (EMA). 14 September 2021. Archived from the original on 24 April 2022. Retrieved 23 April 2022. "Hulio EPAR". European Medicines...
    91 KB (6,940 words) - 04:46, 30 April 2024
  • copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged. "Pyzchiva EPAR". European Medicines Agency. February...
    25 KB (1,922 words) - 02:45, 30 April 2024
  • Thumbnail for Metamizole
    population as opposed to Spaniards. An assessment report by the European Medicines Agency remarked that "the potential to induce agranulocytosis may be...
    53 KB (4,614 words) - 04:59, 3 May 2024
  • Thumbnail for Hexavalent vaccine
    H-W-2495". European Medicines Agency (EMA). Archived from the original on 2 October 2018. Retrieved 28 June 2018. "Hexyon EPAR". European Medicines Agency (EMA)...
    14 KB (1,021 words) - 18:26, 16 September 2023
  • the European Medicines Agency in January 2023. On 20 July 2023, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...
    13 KB (1,033 words) - 03:46, 8 February 2024
  • approved by the health agency of the country like FDA (Food and Drug Administration) for USA, or EMA (European Medicines Agency) for Europe. Regulatory professionals...
    9 KB (1,059 words) - 11:56, 16 February 2024
  • Thumbnail for Rimegepant
    Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion, recommending the granting of...
    14 KB (804 words) - 03:51, 31 March 2024
  • Bevacizumab (category World Health Organization essential medicines)
    which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged. "Aybintio EPAR". European Medicines Agency (EMA). 26...
    79 KB (7,144 words) - 06:09, 17 April 2024
  • Thumbnail for Cabotegravir
    Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion, recommending the granting of...
    25 KB (1,916 words) - 21:37, 20 December 2023
  • Thumbnail for Ruxolitinib
    which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged. "Opzelura EPAR". European Medicines Agency. 20 April...
    26 KB (2,090 words) - 02:10, 2 April 2024
  • Thumbnail for History of COVID-19 vaccine development
    (Press release). European Medicines Agency. 6 January 2021. Archived from the original on 17 March 2021. Retrieved 6 January 2021. "European Commission authorises...
    122 KB (11,028 words) - 02:32, 27 January 2024
  • Thumbnail for Natalizumab
    copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged. "Tyruko EPAR". European Medicines Agency. 28 September...
    43 KB (3,968 words) - 06:52, 27 January 2024